BioMaxima S.A.
ISIN: PLBIOMX00015 | Ticker: BMX | LEI: 2594007GAALFMXP4YB89
Country: Poland
BioMaxima S.A. is a Polish company listed on GPW Main Market, producer of microbiology media as well as a wide range of reagents and in vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical, Biologist. The company holds Certificates of the Quality Management System ISO 9001: 2015 and ISO 13485:2016. Company's products are CE marked and meet the requirements of the Parliament and of the Council (EU) 2017/746. Owing to a wide range of products, BioMaxima is a significant partner for many clients from the clinical, veterinary and industrial diagnostics market both in Poland (where we supply over 1800 laboratories) and in international markets, where we serve over 60 distributors on four continents.
Year founded1997
Served areaWorldwide
HeadquartersVetterów 5, 20-277 Lublin – Poland
| Line item in (pln) | 02.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Assets | N/A | 61,929,000.00 | 74,421,000.00 |
| Noncurrent Assets | N/A | 28,384,000.00 | 38,196,000.00 |
| Property Plant And Equipment | N/A | 27,869,000.00 | 37,761,000.00 |
| Goodwill | N/A | 0.00 | 0.00 |
| Intangible Assets Other Than Goodwill | N/A | 501,000.00 | 435,000.00 |
| Deferred Tax Assets | N/A | 0.00 | 0.00 |
| Other Noncurrent Financial Assets | N/A | 14,000.00 | 0.00 |
| Current Assets | N/A | 33,545,000.00 | 36,225,000.00 |
| Inventories | N/A | 14,024,000.00 | 12,821,000.00 |
| Trade And Other Current Receivables | N/A | 16,512,000.00 | 10,083,000.00 |
| Current Tax Assets Current | N/A | 0.00 | 401,000.00 |
| Other Current Financial Assets | N/A | 13,000.00 | 13,000.00 |
| Cash and cash equivalents | 4,386,000.00 | 2,996,000.00 | 12,907,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 33,545,000.00 | 36,225,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | 0.00 |
| Equity And Liabilities | N/A | 61,929,000.00 | 74,421,000.00 |
| Equity | 19,885,000.00 | 29,193,000.00 | 52,456,000.00 |
| Issued Capital | N/A | 4,320,000.00 | 4,329,000.00 |
| Retained Earnings | N/A | 12,239,000.00 | 34,176,000.00 |
| Share Premium | N/A | 9,841,000.00 | 9,841,000.00 |
| Treasury Shares | N/A | 0.00 | 5,000,000.00 |
| Other Reserves | N/A | 2,793,000.00 | 9,110,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 29,193,000.00 | 52,456,000.00 |
| Noncontrolling Interests | N/A | 0.00 | 0.00 |
| Liabilities | N/A | 32,736,000.00 | 21,965,000.00 |
| Noncurrent Liabilities | N/A | 15,388,000.00 | 10,988,000.00 |
| Noncurrent Provisions | N/A | 62,000.00 | 93,000.00 |
| Noncurrent Government Grants | N/A | 6,173,000.00 | 6,019,000.00 |
| Deferred Tax Liabilities | N/A | 533,000.00 | 766,000.00 |
| Other Noncurrent Financial Liabilities | N/A | 8,020,000.00 | 3,861,000.00 |
| Other Noncurrent Nonfinancial Liabilities | N/A | 0.00 | 0.00 |
| Current Liabilities | N/A | 17,348,000.00 | 10,977,000.00 |
| Current Provisions | N/A | 792,000.00 | 1,393,000.00 |
| Trade And Other Current Payables | N/A | 6,719,000.00 | 7,389,000.00 |
| Current Government Grants | N/A | 478,000.00 | 477,000.00 |
| Current Tax Liabilities Current | N/A | 708,000.00 | 0.00 |
| Other Current Financial Liabilities | N/A | 8,142,000.00 | 1,305,000.00 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 17,348,000.00 | 10,977,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | 0.00 |
| Line item in (pln) | 01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|
| Revenue | 79,088,000.00 | 143,867,000.00 |
| Other Income | 1,997,000.00 | 1,647,000.00 |
| Changes In Inventories Of Finished Goods And Work In Progress | 2,192,000.00 | 318,000.00 |
| Other Work Performed By Entity And Capitalised | 637,000.00 | 1,677,000.00 |
| Raw Materials And Consumables Used | 37,890,000.00 | 77,710,000.00 |
| Cost Of Merchandise Sold | 9,498,000.00 | 11,511,000.00 |
| Services Expense | 4,716,000.00 | 5,030,000.00 |
| Employee Benefits Expense | 10,570,000.00 | 12,457,000.00 |
| Depreciation And Amortisation Expense | 1,654,000.00 | 2,020,000.00 |
| Other Expense By Nature | 1,152,000.00 | 1,775,000.00 |
| Profit Loss From Operating Activities | 13,653,000.00 | 34,854,000.00 |
| Finance Income | 100,000.00 | 1,465,000.00 |
| Finance Costs | 322,000.00 | 486,000.00 |
| Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | 656,000.00 | -36,000.00 |
| Profit Loss Before Tax | 12,775,000.00 | 35,869,000.00 |
| Income Tax Expense Continuing Operations | 2,532,000.00 | 6,984,000.00 |
| Profit Loss From Continuing Operations | 10,243,000.00 | 28,885,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 |
| Profit (loss) | 10,243,000.00 | 28,885,000.00 |
| Profit Loss Attributable To Owners Of Parent | 10,243,000.00 | 28,885,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 |
| Line item in (pln) | 01.01.2022 | 02.01.2021 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 10,243,000.00 | N/A | 28,885,000.00 |
| Adjustments For Reconcile Profit Loss | -11,157,000.00 | N/A | 8,288,000.00 |
| Adjustments For Decrease Increase In Inventories | -3,627,000.00 | N/A | 1,030,000.00 |
| Adjustments For Depreciation And Amortisation Expense | 1,654,000.00 | N/A | 2,020,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | N/A | 0.00 |
| Adjustments For Provisions | 561,000.00 | N/A | 633,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | 77,000.00 | N/A | -26,000.00 |
| Adjustments For Sharebased Payments | 0.00 | N/A | 0.00 |
| Adjustments For Fair Value Gains Losses | 0.00 | N/A | 0.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -54,000.00 | N/A | -1,000.00 |
| Adjustments For Reconcile Profit Loss | -11,157,000.00 | N/A | 8,288,000.00 |
| Cash Flows From Used In Operations | 1,618,000.00 | N/A | 44,157,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 1,750,000.00 | N/A | 7,092,000.00 |
| Cash Flows From Used In Operating Activities | -132,000.00 | N/A | 37,065,000.00 |
| Proceeds From Government Grants Classified As Investing Activities | 834,000.00 | N/A | 1,226,000.00 |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | 0.00 | N/A | 0.00 |
| Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities | 13,000.00 | N/A | 10,000.00 |
| Dividends Received Classified As Investing Activities | 0.00 | N/A | 0.00 |
| Interest Received Classified As Investing Activities | 0.00 | N/A | 811,000.00 |
| Cash Flows From Used In Investing Activities | -3,368,000.00 | N/A | -7,831,000.00 |
| Payments From Changes In Ownership Interests In Subsidiaries | 0.00 | N/A | 0.00 |
| Proceeds From Issuing Shares | 0.00 | N/A | 9,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | 0.00 | N/A | 5,000,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 7,525,000.00 | N/A | 5,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 2,591,000.00 | N/A | 10,820,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 1,558,000.00 | N/A | 1,102,000.00 |
| Dividends Paid Classified As Financing Activities | 1,097,000.00 | N/A | 1,948,000.00 |
| Interest Paid Classified As Financing Activities | 169,000.00 | N/A | 467,000.00 |
| Cash Flows From Used In Financing Activities | 2,110,000.00 | N/A | -19,323,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -1,390,000.00 | N/A | 9,911,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 0.00 | N/A | 0.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | -1,390,000.00 | N/A | 9,911,000.00 |
| Cash and cash equivalents | 2,996,000.00 | 4,386,000.00 | 12,907,000.00 |
Please note that some sums might not add up.
PLBIOMX00015
LEI2594007GAALFMXP4YB89
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.